EE586 Cost-Utility of Cladribine Tablets and Dimethyl Fumarate in the Treatment of Relapsing Remitting Multiple Sclerosis From the Societal Perspective in Spain
Dec 1, 2022, 00:00
10.1016/j.jval.2022.09.826
https://www.valueinhealthjournal.com/article/S1098-3015(22)03030-3/fulltext
Title :
EE586 Cost-Utility of Cladribine Tablets and Dimethyl Fumarate in the Treatment of Relapsing Remitting Multiple Sclerosis From the Societal Perspective in Spain
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(22)03030-3&doi=10.1016/j.jval.2022.09.826
First page :
Section Title :
Open access? :
No
Section Order :
10367